TalkMarkets Newswire Blog | Talkmarkets | Page 1
Company News & Information

TalkMarkets Newswire is a premier service which disseminates and distributes critical news, press releases and information about a variety of companies. This information is seen by readers not only on TalkMarkets, but also goes out to our distribution partners which include such leading ... more

Articles

Latest Posts
1 to 16 of 16 Posts
SinglePoint Enters Into Letter Of Intent To Acquire EnergyWyze, LLC To Streamline, Optimize, And Maximize Solar Industry Lead Generation
Agreement signifies a key step towards solidifying a leadership position in the solar industry.
American Resources, Wholly Owned Subsidiary, American Rare Earth LLC Enters Into Joint Venture To Develop And Commercialize Critical Element And Graphene Technologies
Joint venture partners with Gerardine Botte, Ph.D., Texas Tech University Professor and Department Chair to develop and commercialize technologies production from carbon-based deposits.
American Resources Corporation Unveils Rare Earth Element Wholly Owned Subsidiary, American Rare Earth LLC
American Resources Corporation, a supplier of raw materials to the rapidly growing global infrastructure marketplace, today unveiled its wholly owned subsidiary, American Rare Earth LLC ("American Rare Earth").
Sonnet BioTherapeutics Receives $10.5 Million From Exercise Of Series A Warrants
Sonnet Bio announced today that, as part of the previously announced warrant exchange agreement, all 3,300,066 Series A Warrants have been exercised at a price of $3.19 per share. Gross proceeds to the Company were $10.5 Million.
Protalix BioTherapeutics Announces FDA Acceptance Of BLA For The Treatment Of Fabry Disease And Grants Priority Review
Priority Review is granted to therapies that the FDA determines have the potential to provide significant improvements in the treatment, diagnosis or prevention of serious conditions.
VistaGen Therapeutics Announces Positive Meeting With FDA Regarding Pivotal Phase 3 Study Of PH94B For Acute Treatment Of Anxiety In Patients With Social Anxiety Disorder
VistaGen and the FDA reached consensus on key aspects of a unique initial pivotal Phase 3 clinical trial of PH94B involving a single-event, laboratory-simulated public speaking challenge in adult patients with SAD.
CytoDyn Files Application With Nasdaq For Uplist
CytoDyn Inc., announced today it recently filed a comprehensive listing application package with The Nasdaq Stock Market to request an uplisting of the Company’s common stock.
Vaccinex Provides Update Of Potentially Pivotal SIGNAL Clinical Trial In Huntington’s Disease
Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs.
VistaGen Therapeutics And EverInsight Therapeutics Enter Strategic Collaboration To Develop And Commercialize PH94B For Anxiety Disorders In Greater China, South Korea And Southeast Asia
The collaboration is intended to support Phase 3 development and commercialization of PH94B in key Asian markets. The agreement includes a $5 million upfront payment and development and commercial milestones up to $172 million.
AMERI Holdings Amalgamation Partner Jay Pharma Reports IRB Approval For Testing Proprietary CBD Formulation In Brain Cancer
Final approval is anticipated in summer 2020 to initiate phase I/II study in Glioblastoma Multiforme. The study will enroll 40 patients with recurrent or progressive GBM tumors who are currently undergoing chemotherapy.
Soligenix Announces Positive Top-line Results For Its Pivotal Phase 3 FLASH Trial Evaluating SGX301 In Treatment Of Cutaneous T-Cell Lymphoma
Soligenix announced positive preliminary top-line results for its pivotal Phase 3 FLASH trial evaluating SGX301 in the treatment of cutaneous T-cell lymphoma. The company will host an Investor Conference Call today at 8:30AM EDT,
Ticker Tocker Announces New Partnership With TalkMarkets To Drive Major Players To Its Growing Leader Portal
Ticker Tocker, an intuitive trading platform that connects investors to top trading leaders, announced its newest partnership today with social financial platform, TalkMarkets.
TEFS Announces Improved Terms For Its Providers
In a statement today, TEFS, a Seychelles based private investment firm, made several announcements that were defined as “new and exciting”. The statement is intended for Providers* who trade TEFS’s funds using the TEFS trading platform.
CytoDyn And Samsung BioLogics Enter Into Agreement To Manufacture $1 Billion Worth Of Leronlimab (PRO 140) To Meet Expected Demand For Future Revenues Post-Approval
CytoDyn, a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced the execution of a comprehensive strategic agreement with Samsung BioLogics.
Chase To Assist Federal Employees Affected By Government Shutdown
Chase (CCF) today announced efforts to help its customers who are U.S. government employees affected by the U.S. government shutdown.
BiondVax Receives €8m From The European Investment Bank
The money from the EIB is in support of manufacturing facility and ongoing Phase 3 clinical trial.
1 to 16 of 16 Posts